Citius Oncology CTOR
NASDAQ CTOR
$0.56 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Citius Oncology (CTOR) Price to Earnings (2023)

Updated

Citius Oncology's Price to Earnings was 305.23 in FY2023 (year ended Dec 31, 2023), up 256.7% from 85.57 in FY2022.

Analysis

Citius Oncology (CTOR) Price to Earnings (2023) Analysis & Trends

  • Per Business Quant data, Price to Earnings in earlier fiscal years was 85.57 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Citius Oncology 60.42 Mn 30.00 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 69.48
API Access

Citius Oncology Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CTOR&period=max&api_key=YOUR_API_KEY